6 August, 2025
Recent data from Birmingham’s regional neoadjuvant programme for pancreatic cancer, headed up by Medmin’s own Mr. Nikolaos Chatzizacharias, challenges the notion that surgery is off the table for patients with borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma [...]